SynthesisInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2017

Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non-Bevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer.

Virginia M Rosen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.